Text Size

Progress Pediatric Study

This study is currently recruiting participants.
Verified April 2011 by The HIV Netherlands Australia Thailand Research Collaboration
Sponsor:
Collaborators:
Bamrasnaradura Infectious Diseases Institute
Mahidol University
Chiangrai Prachanukroh Hospital
Sanpatong Hospital
Information provided by:
The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT01328288
First received: March 2, 2011
Last updated: April 1, 2011
Last verified: April 2011
History of Changes
  Purpose

The purpose of this study is to study the HIV disease progression in HIV-infected Thai children.


Condition Intervention
Acquired Immunodeficiency Syndrome
Depression
 Drug: standard ART according to the Thai Ministry of Public Health national guidelines

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Thai Pediatric HIV Disease Progression: An Observational Database

Resource links provided by NLM:

MedlinePlus related topics: Depression HIV/AIDS
U.S. FDA Resources

Further study details as provided by The HIV Netherlands Australia Thailand Research Collaboration:

Primary Outcome Measures:
  • HIV related adverse events [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    time to HIV related adverse events


Secondary Outcome Measures:
  • Immunological failure [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    time to immunological failure

  • virological failure [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    time to virological failure

  • quality of life [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    time to change of quality of life

  • depression [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    when patient develops depression

  • genotypic resistance [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    time to genotypic resistance


Biospecimen Retention:   Samples With DNA

serum


Estimated Enrollment: 840
Study Start Date: January 2009
Estimated Study Completion Date: September 2015
Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
long-term follow-up of HIV-infected children
 Drug: standard ART according to the Thai Ministry of Public Health national guidelines
Patients may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.

Detailed Description:

This is a multicenter, observational cohort study. HIV-infected children from 5 institutions are followed to assess HIV disease progression: 1. Bamrasnaradura infectious disease institute,2. Faculty of Medicine Siriraj Hospital, Mahidol University, 3. Chiangrai Prachanukroh Hospital, 4. Sanpatong Hospital and 5. HIV-NAT, Thai Red Cross AIDS Research Center.

  Eligibility

Ages Eligible for Study:   up to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

long-term follow-up of HIV-infected children from: 1. Bamrasnaradura infectious disease institute, 2. Faculty of Medicine Siriraj Hospital, Mahidol University, 3. Chiangrai Prachanukroh Hospital, Chiang Rai, 4. Sanpatong Hospital, Chiang Mai, and 5. HIV-NAT, Thai Red Cross AIDS Research Center, Bangkok

Criteria

Inclusion Criteria:

  1. age < 18 years old
  2. Have confirmed HIV infection (ELISA,HIV-DNA PCR,HIV-RNA PCR)
  3. Signed consent form

Exclusion Criteria:

  1. Hospitalization
  2. Emergency case
  3. Incomplete Medical Record
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01328288

Contacts
Contact: Wisit Prasithsirikul, MD 6625903408 drwisit_p@yahoo.com
Contact: Kulkanya Chokephaibulkit, MD 66816110371 sikch@mahidol.ac.th

Locations
Thailand
Sanpatong Hospital Recruiting
Sanpathong, Chiang Mai, Thailand
Contact: Wirat Klinbuayam, MD            
Principal Investigator: Wirat Klinbuayam, MD            
Faculty of Medicine Siriraj Hospital, Mahidol University Recruiting
Bangkok, Thailand
Contact: Kulkanya Chokephaibulkit, MD         sikch@mahidol.ac.th    
Principal Investigator: Kulkanya Chokephaibulkit, MD            
HIV-NAT, Thai Red Cross AIDS Research Center Recruiting
Bangkok, Thailand, 10330
Contact: Jintanat Ananworanich, MD, PhD     662-652-3040 ext 280     jintanat.a@hivnat.org    
Principal Investigator: Jintanat Ananworanich, MD, PhD            
Chiangrai Prachanukroh Hospital Recruiting
Chiang Rai, Thailand
Contact: Rawiwan Hansudewechakul, MD            
Principal Investigator: Rawiwan Hansudewechakul, MD            
Bamrasnaradura infectious disease institute Recruiting
Nonthaburi, Thailand, 11000
Contact: Wisit Prasithsirikul, MD            
Principal Investigator: Wisit Prasithsirikul, MD            
Sponsors and Collaborators
The HIV Netherlands Australia Thailand Research Collaboration
Bamrasnaradura Infectious Diseases Institute
Mahidol University
Chiangrai Prachanukroh Hospital
Sanpatong Hospital
Investigators
Principal Investigator: Wisit Prasithsirikul, MD Bamrasnaradura infectious disease institute
Principal Investigator: Rawiwan Hansudewechakul, MD Chiangrai Prachanukroh Hospital
Principal Investigator: Wirat Klinbuayam, MD Sanpatong Hospital
Principal Investigator: Jintanat Ananworanich, MD, PhD HIV-NAT, Thai Red Cross AIDS Research Center
Principal Investigator: Kulkanya Chokephaibulkit, MD Mahidol University
  More Information

Additional Information:
HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Wisit Prasithsirikul, Bamrasnaradura Infectious Disease Institute
ClinicalTrials.gov Identifier: NCT01328288     History of Changes
Other Study ID Numbers: HIV-NAT 154
Study First Received: March 2, 2011
Last Updated: April 1, 2011
Health Authority: Thailand: Ethical Committee

Keywords provided by The HIV Netherlands Australia Thailand Research Collaboration:
HIV related adverse events
Immunological failure
virological failure
 quality of life
depression
genotypic resistance

Additional relevant MeSH terms:
Acquired Immunodeficiency Syndrome
HIV Infections
Depression
Depressive Disorder
Immunologic Deficiency Syndromes
Disease Progression
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
 Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Slow Virus Diseases
Immune System Diseases
Behavioral Symptoms
Mood Disorders
Mental Disorders
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on March 07, 2013